Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Mis-spliced RNAs in tumor cells trigger antiviral response

Jan. 15, 2021

New classification scheme for glioblastomas

Jan. 15, 2021

CJ-2360 achieves complete tumor regression in ALK-positive xenografts

Jan. 15, 2021

Array BioPharma discloses BRAF mutant inhibitors

Jan. 15, 2021

DNA base composition determines oncogene function

Jan. 14, 2021

Phase Ib study of zotiraciclib in recurrent high-grade gliomas meets its prespecified endpoint

Jan. 14, 2021

Pfizer and CTxT Pty divulge new KAT inhibitors

Jan. 13, 2021

Dana-Farber Cancer Institute synthesizes new EGFR inhibitors

Jan. 13, 2021

Initiation of pivotal global study evaluating CLR-131 in Waldenstrom's macroglobulinemia

Jan. 13, 2021

Helsinn begins phase I/II study of oral RET inhibitor TAS-0953 in advanced solid tumors

Jan. 12, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...